These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6835989)

  • 41. Effect of pentylenetetrazol on carbaryl-induced changes in striatal catecholamines.
    Ray SK; Poddar MK
    Biochem Pharmacol; 1985 Feb; 34(4):553-7. PubMed ID: 3918540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dopamine receptors and ergot drugs. Evidence that an ergolene derivative is a differential agonist at subcortical limbic dopamine receptors.
    Fuxe K; Fredholm BB; Agnati LF; Corrodi H
    Brain Res; 1978 May; 146(2):295-311. PubMed ID: 647392
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monoamine innervation of the forebrain: collateralization.
    Fallon JH; Loughlin SE
    Brain Res Bull; 1982; 9(1-6):295-307. PubMed ID: 6129040
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential effects of ascending neurons containing dopamine and noradrenaline in the control of spontaneous activity and of evoked responses in the rat prefrontal cortex.
    Mantz J; Milla C; Glowinski J; Thierry AM
    Neuroscience; 1988 Nov; 27(2):517-26. PubMed ID: 3146033
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Noradrenergic Modulation of Dopamine Transmission Evoked by Electrical Stimulation of the Locus Coeruleus in the Rat Brain.
    Park JW; Bhimani RV; Park J
    ACS Chem Neurosci; 2017 Sep; 8(9):1913-1924. PubMed ID: 28594540
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biogenic amine turnover in newborn and adult rabbit brainstem nuclei after pargyline administration.
    McNamara MC; Lawson EE
    Respir Physiol; 1984 Dec; 58(3):313-21. PubMed ID: 6528107
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased utilization of dopamine in the nucleus accumbens but not in the cerebral cortex after dorsal raphe lesion in the rat.
    Hervé D; Simon H; Blanc G; Lisoprawski A; Le Moal M; Glowinski J; Tassin JP
    Neurosci Lett; 1979 Dec; 15(2-3):127-33. PubMed ID: 530523
    [TBL] [Abstract][Full Text] [Related]  

  • 48. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal.
    Devoto P; Flore G; Pira L; Diana M; Gessa GL
    Psychopharmacology (Berl); 2002 Mar; 160(2):220-4. PubMed ID: 11875641
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phencyclidine suppresses the activity of midbrain dopamine-containing neurons recorded from mouse brain slices in vitro.
    Trulson ME; Arasteh K
    Eur J Pharmacol; 1987 Jan; 133(3):345-9. PubMed ID: 3556396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of corticosterone on noradrenergic nuclei in the pons-medulla and [3H]NA release from terminals in hippocampal slices.
    de Villiers AS; Russell VA; Taljaard JJ
    Neurochem Res; 1992 Mar; 17(3):273-80. PubMed ID: 1620270
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacological study on the mixed CCK8/DA meso-nucleus accumbens pathway: evidence for the existence of storage sites containing the two transmitters.
    Studler JM; Reibaud M; Tramu G; Blanc G; Glowinski J; Tassin JP
    Brain Res; 1984 Apr; 298(1):91-7. PubMed ID: 6326949
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regional changes in [3H]-noradrenaline uptake, catecholamines and catecholamine synthetic and catabolic enzymes in rat brain following neonatal 6-hydroxydopamine treatment.
    Jonsson G; Sachs C
    Med Biol; 1976 Aug; 54(4):286-97. PubMed ID: 8670
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of excitotoxin lesions in the medical prefrontal cortex on cortical and subcortical catecholamine turnover in the rat.
    Christie MJ; Rowe PJ; Beart PM
    J Neurochem; 1986 Nov; 47(5):1593-7. PubMed ID: 3531406
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Partial protection by desmethylimipramine of the mesocortical dopamine neurones from the neurotoxic effect of 6-hydroxydopamine injected in ventral mesencephalic tegmentum. The role of noradrenergic innervation.
    Herve D; Studler JM; Blanc G; Glowinski J; Tassin JP
    Brain Res; 1986 Sep; 383(1-2):47-53. PubMed ID: 3094831
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Histochemical mapping of dopamine neurons and fiber pathways in dog mesencephalon.
    Shimada S; Ishikawa M; Tanaka C
    J Comp Neurol; 1976 Aug; 168(4):533-43. PubMed ID: 939821
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of prostaglandins on catecholamine metabolism of the central nervous system in rats.
    Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 57(3):221-4. PubMed ID: 6946681
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Organization of thalamic projections in the nucleus accumbens and the caudate nucleus in cats and its relation with hippocampal and other subcortical afferents.
    Jayaraman A
    J Comp Neurol; 1985 Jan; 231(3):396-420. PubMed ID: 3968245
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intracerebral MPTP injections in the rat cause cell loss in the substantia nigra, ventral tegmental area and dorsal raphe.
    Takada M; Li ZK; Hattori T
    Neurosci Lett; 1987 Jul; 78(2):145-50. PubMed ID: 3498132
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hippocampal signal transmission to the pedunculopontine nucleus and its regulation by dopamine D2 receptors in the nucleus accumbens: an electrophysiological and behavioural study.
    Yang CR; Mogenson GJ
    Neuroscience; 1987 Dec; 23(3):1041-55. PubMed ID: 2963972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.